If you’re managing alcohol use disorder, medication-assisted treatment (MAT) gives you evidence-based tools that target the brain changes driving drinking. You’ve got three FDA-approved options: naltrexone reduces cravings and blocks alcohol’s rewarding effects, acamprosate helps you maintain abstinence after detox, and disulfiram deters drinking through unpleasant reactions. Medication works best alongside counseling, it’s not a cure by itself. Understanding how each option fits your abstinence status and goals can shape your recovery.
Key Takeaways
- Medication-assisted treatment (MAT) targets alcohol-driven brain changes, reducing cravings and reinforcement that willpower alone often cannot overcome.
- Naltrexone (oral 50 mg/day or long-acting injectable) blocks alcohol’s rewarding effects and is a first-line, evidence-based option.
- Acamprosate helps maintain abstinence after detox, typically started around the 5th to 8th day of not drinking.
- Disulfiram deters drinking through unpleasant reactions like vomiting and chest pain, but doesn’t reduce cravings.
- MAT works best combined with counseling and behavioral therapy, not as a standalone cure for alcohol use disorder.
Why medication helps with alcohol use disorder
Medication helps with alcohol use disorder because it targets the brain chemistry changes that drive drinking, providing biological support that willpower alone often can’t sustain. Repeated heavy drinking alters the brain’s reward and stress systems, driving cravings and reinforcing the compulsion to drink. Medication-assisted treatment (MAT) targets these underlying changes directly, giving you biological support that behavioral effort can’t fully provide on its own.
FDA-approved medications work in different ways: some reduce alcohol’s rewarding effects, others help stabilize brain chemistry to maintain abstinence. By lowering cravings and reducing the drive to drink, these medications make it easier for you to engage in counseling and rebuild daily function.
MAT isn’t a cure, and it works best alongside therapy and support services. Still, it’s an evidence-based tool that meaningfully improves your odds of lasting recovery.
Naltrexone for alcohol
Naltrexone works by blocking the opioid receptors involved in alcohol’s rewarding effects, reducing the “buzz” that reinforces drinking. You’re less likely to keep drinking, and your cravings often ease. This makes naltrexone a strong first-line option, supported by a 2024 meta-analysis of 118 trials showing oral naltrexone at 50 mg/day improves alcohol consumption outcomes versus placebo.
You’ve got two forms to evaluate, depending on your needs and adherence.
| Form | Key Consideration |
|---|---|
| Oral (50 mg/day) | Evidence-backed first-line therapy |
| Long-acting injectable | Useful when daily adherence is a concern |
| Both forms | Reduce alcohol’s reinforcement and cravings |
| Treatment context | Combined with counseling for best results |
You’ll get the strongest results pairing naltrexone with ongoing behavioral support.
Acamprosate
Acamprosate works best after you’ve already stopped drinking, unlike naltrexone. It’s designed to help you maintain abstinence and reduce relapse risk after detoxification or in early recovery, rather than treat acute withdrawal symptoms. Because of this, you’ll typically start it once you’ve been abstinent for several days, some sources specify around the 5th day, while others recommend waiting 5 to 8 days.
Acamprosate is taken orally and stands alongside naltrexone as a first-line AUD medication. The 2024 systematic review and meta-analysis of 118 trials and 20,976 participants confirmed it improves alcohol consumption outcomes versus placebo. If your goal is sustained abstinence and relapse prevention, acamprosate can support your recovery, especially when you combine it with counseling and ongoing behavioral therapies.
Disulfiram
Disulfiram deters you from drinking by causing unpleasant reactions if you consume alcohol. If you drink while taking it, you’ll likely experience symptoms such as vomiting, chest pain, and trouble breathing. This aversive response is what discourages you from returning to alcohol. Naltrexone and acamprosate reduce cravings, but disulfiram takes a different approach.
Because disulfiram doesn’t reduce cravings or block alcohol’s rewarding effects, it works differently than first-line options. You’ll typically start it after detoxification or during a period of abstinence, using it to lower your relapse risk.
Disulfiram is FDA-approved for AUD, but several sources describe it as less consistently supported or more situational than naltrexone and acamprosate. For that reason, you’ll usually see it considered when other treatments aren’t a good fit.
How alcohol MAT differs from opioid MAT
Alcohol MAT and opioid MAT use different medications because they target different disorders. For AUD, you’ll use FDA-approved options like naltrexone, acamprosate, and disulfiram, which reduce cravings, lower alcohol’s rewarding effects, or deter drinking. These medications address alcohol’s specific impact on brain chemistry and reinforcement.
Opioid MAT relies on different agents. Methadone and buprenorphine are approved for opioid use disorder, not AUD, and they work on opioid receptors to manage dependence and withdrawal in ways that don’t apply to alcohol.
There’s some overlap with naltrexone, which is approved for both conditions. For AUD, it blocks opioid receptors involved in alcohol’s rewarding effects. For OUD, its long-acting injectable form supports recovery. Understanding these distinctions helps you match the right medication to the right disorder.
What to expect
Treatment starts with an FDA-approved medication, naltrexone, acamprosate, or disulfiram, chosen based on your abstinence status, relapse risk, and treatment goals. Medication alone isn’t the whole plan. You’ll combine it with counseling or behavioral therapy, which strengthens your outcomes. If you’re aiming to reduce alcohol’s reward and heavy drinking, expect naltrexone, available orally or as a long-acting injectable when daily adherence is a concern. If you’ve already stopped drinking and want to maintain abstinence, you’ll likely start acamprosate around the fifth to eighth day. Remember, these medications reduce cravings and lower relapse risk, they’re not a cure. Ongoing support services help you sustain progress throughout recovery.
Combining medication with counseling
Combining medication with counseling gives you the best results because MAT for AUD is an evidence-based approach rather than a stand-alone fix. Medications like naltrexone and acamprosate reduce cravings and stabilize brain chemistry, but they work best as part of a broader recovery plan. Counseling addresses the behavioral and psychological factors your medication can’t reach.
Medication eases cravings, but counseling reaches the behavioral factors medication can’t together, they build your strongest path to recovery.
Here’s what combining both can look like for you:
- Taking naltrexone or acamprosate while attending regular therapy sessions
- Building coping skills to manage triggers and high-risk situations
- Setting clear goals, whether abstinence, reduced heavy drinking, or relapse prevention
- Accessing ongoing support services that reinforce your progress
- Adjusting your medication based on adherence, tolerability, and treatment response
Together, these strengthen your long-term outcomes.
Cravings Running the Show? There’s Medication for That.
Willpower isn’t the only tool for alcohol recovery, medications like naltrexone and acamprosate can quiet cravings and steady you while the real work happens. Simonds Recovery Centers in Granada Hills pairs medication-assisted treatment for alcohol use with the therapy that makes it last, starting with medical detox if your body needs to clear first.
Call (833) 781-8338 now or verify your insurance. Confidential, seven days a week.
Frequently Asked Questions
How Long Do People Typically Stay on AUD Medications?
Your treatment duration depends on your recovery goals, relapse risk, and how well you tolerate the medication, there’s no fixed timeline. You’ll typically stay on AUD medications as part of a broader, evidence-based plan that includes counseling and behavioral therapies. Since MAT isn’t a cure, your provider may continue medications like naltrexone or acamprosate while you’re building stability. Ongoing support services often strengthen your outcomes, so you’ll adjust duration based on progress.
Are MAT Medications for AUD Covered by Insurance?
Coverage varies by your specific insurance plan, so you’ll want to verify your benefits directly. That said, the knowledge provided here doesn’t include details about insurance coverage for AUD medications like naltrexone, acamprosate, or disulfiram. To get accurate answers, you should contact your insurance provider or ask your treatment team, since they can confirm which medications and MAT services your plan covers and what costs you’ll face.
Can I Take AUD Medications While Pregnant or Breastfeeding?
You should discuss this carefully with your doctor before taking any AUD medication while pregnant or breastfeeding. The knowledge provided here doesn’t include specific safety data for naltrexone, acamprosate, or disulfiram during pregnancy or lactation. Because these decisions depend on your individual risks, treatment goals, and your baby’s safety, you’ll need personalized medical guidance. Don’t start, stop, or change any medication on your own, talk with your healthcare provider first.
Do These Medications Interact With Other Prescription Drugs?
Yes, these medications can interact with other prescription drugs. Naltrexone blocks opioid receptors, so it interacts with opioid pain medications and can trigger withdrawal or reduce their effectiveness. Disulfiram may interact with medications containing alcohol and certain drugs, causing serious reactions. Acamprosate has fewer known interactions but still warrants review. You should share your complete medication list with your provider so they can check for potential interactions and adjust your treatment safely.
Can I Get AUD Medications Through Telehealth or Online Providers?
Yes, you can often access AUD medications through telehealth or online providers, depending on your location and applicable regulations. Many clinicians can evaluate you virtually, prescribe naltrexone or acamprosate, and coordinate counseling or behavioral support remotely. Keep in mind that some providers may require baseline labs or in-person assessment before starting treatment. You’ll also want to confirm that your chosen platform combines medication with evidence-based psychosocial support for better outcomes.